...
首页> 外文期刊>Liver international : >Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
【24h】

Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis

机译:肠道屏障功能的循环标记与原发性硬化性胆管炎中疾病严重程度相关的血压屏障功能

获取原文
获取原文并翻译 | 示例
           

摘要

Background & Aims One important hypothesis in primary sclerosing cholangitis pathophysiology suggests that bacterial products from an inflamed leaky gut lead to biliary inflammation. We aimed to investigate whether circulating markers of bacterial translocation were associated with survival in a Norwegian primary sclerosing cholangitis cohort. Methods Serum levels of zonulin, intestinal fatty acid binding protein, soluble CD14, lipopolysaccharide and lipopolysaccharide-binding protein were measured in 166 primary sclerosing cholangitis patients and 100 healthy controls. Results Lipopolysaccharide-binding protein and soluble CD14 were elevated in primary sclerosing cholangitis compared with healthy controls (median 13 662 vs 12 339 ng/mL, P = 0.010 and 1657 vs 1196 ng/mL, P 0.001, respectively). High soluble CD14 and lipopolysaccharide-binding protein (values optimal cut-off using receiver operating characteristics) were associated with reduced liver transplantation-free survival (P P = 0.005, respectively). The concentration of soluble CD14 was higher in patients with hepatobiliary cancer compared to other primary sclerosing cholangitis patients and healthy controls. Zonulin was lower in primary sclerosing cholangitis than controls, but when excluding primary sclerosing cholangitis patients with increased prothrombin time zonulin concentrations were similar in primary sclerosing cholangitis and healthy controls. Concomitant inflammatory bowel disease did not influence the results, while inflammatory bowel disease patients without primary sclerosing cholangitis (n = 40) had lower concentration of soluble CD14. In multivariable Cox regression, high soluble CD14 and high lipopolysaccharide-binding protein were associated with transplantation-free survival, independent from Mayo risk score (HR: 2.26 [95% CI: 1.15-4.43], P = 0.018 and HR: 2.00 [95% CI: 1.17-3.43], P = 0.011, respectively). Conclusions Primary sclerosing cholangitis patients show increased levels of circulating markers of bacterial translocation. High levels are associated with poor prognosis measured by transplantation-free survival, indicating that ongoing gut leakage could have clinical impact in primary sclerosing cholangitis.
机译:背景和AIMS原发性硬化胆管炎病症的一个重要假设表明,来自发炎的泄漏肠道的细菌产品导致胆汁炎症。我们的目标是调查细菌易位的循环标志是否与挪威初级硬化性胆管炎队列的生存相关。方法测定166名初级硬膜胆管炎患者和100名健康对照中测定血清素,肠脂肪酸结合蛋白,可溶性CD14,脂多糖和脂多糖结合蛋白的血清水平。结果脂多糖结合蛋白和可溶性CD14与健康对照相比,在原发性硬化胆管炎中升高(中值13 662 vs12339ng / ml,P = 0.010和1657 Vs 1196ng / ml,P <0.001)。高可溶性CD14和脂多糖结合蛋白(使用接收器操作特性最佳截止)与无肝移植的存活(P P = 0.005分别)相关联。与其他初级硬化胆管炎患者和健康对照相比,肝胆癌患者可溶性CD14的浓度较高。 Zonulin在原发性胆管炎的原发性胆管炎中较低,但是当排除初级硬化的胆管炎患者时,凝血酶原时间增加,Zonulin浓度在原发性胆管炎和健康对照中相似。伴随的炎性肠病疾病没有影响结果,而没有初级硬化胆管炎的炎症性肠病患者(n = 40)浓度较低的可溶性CD14。在多变量的Cox回归中,高可溶性CD14和高脂多糖结合蛋白与无移植的存活率相关,与Mayo风险评分无关(HR:2.26 [95%CI:1.15-43],P = 0.018和HR:2.00 [95] %CI:1.17-3.43],P = 0.011)。结论原发性硬化性胆管炎患者显示细菌易位循环标记水平增加。高水平与通过移植存活率测量的预后差有关,表明正在进行的肠道泄漏可能对原发性硬化胆管炎具有临床影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号